About Quidel Corporation (NASDAQ:QDEL)
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of critical diseases and other medical conditions, including infectious diseases, women's health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, MicroVue, FreshCells, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Quidel Molecular, Amplivue, Lyra and Thyretain.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Advanced Medical Equipment & Technology
- Sub-Industry: Health Care Supplies
- Symbol: NASDAQ:QDEL
- CUSIP: 74838J10
- Web: www.quidel.com
- Market Cap: $1.40282 billion
- Outstanding Shares: 33,440,000
- 50 Day Moving Avg: $41.00
- 200 Day Moving Avg: $31.23
- 52 Week Range: $18.25 - $45.55
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 21.98
- P/E Growth: 7.19
- Annual Revenue: $214.11 million
- Price / Sales: 6.52
- Book Value: $6.36 per share
- Price / Book: 6.57
- EBITDA: $39.38 million
- Net Margins: -0.03%
- Return on Equity: -0.03%
- Return on Assets: -0.02%
- Debt-to-Equity Ratio: 0.71%
- Current Ratio: 7.19%
- Quick Ratio: 6.46%
- Average Volume: 430,905 shs.
- Beta: 1.27
- Short Ratio: 7
Frequently Asked Questions for Quidel Corporation (NASDAQ:QDEL)
What is Quidel Corporation's stock symbol?
Quidel Corporation trades on the NASDAQ under the ticker symbol "QDEL."
How were Quidel Corporation's earnings last quarter?
Quidel Corporation (NASDAQ:QDEL) released its earnings results on Wednesday, July, 26th. The company reported ($0.35) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.17) by $0.18. The firm earned $38.30 million during the quarter, compared to the consensus estimate of $41.91 million. Quidel Corporation had a negative return on equity of 0.03% and a negative net margin of 0.03%. The business's quarterly revenue was down 2.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.11) EPS. View Quidel Corporation's Earnings History.
When will Quidel Corporation make its next earnings announcement?
Where is Quidel Corporation's stock going? Where will Quidel Corporation's stock price be in 2017?
6 equities research analysts have issued 1-year price objectives for Quidel Corporation's stock. Their forecasts range from $45.00 to $50.00. On average, they expect Quidel Corporation's stock price to reach $47.50 in the next year. View Analyst Ratings for Quidel Corporation.
Who are some of Quidel Corporation's key competitors?
Some companies that are related to Quidel Corporation include Mazor Robotics (MZOR), Natus Medical (BABY), Accelerate Diagnostics (AXDX), ABAXIS (ABAX), Luminex Corporation (LMNX), LeMaitre Vascular (LMAT), Pacific Biosciences of California (PACB), GenMark Diagnostics (GNMK), ViewRay (VRAY), Accuray Incorporated (ARAY), Corindus Vascular Robotics (CVRS), Cogentix Medical (CGNT), Cytosorbents Corporation (CTSO), Harvard Bioscience (HBIO), Neovasc (NVCN), IRIDEX Corporation (IRIX), Viveve Medical (VIVE) and Edap Tms S.A. (EDAP).
Who are Quidel Corporation's key executives?
Quidel Corporation's management team includes the folowing people:
- Kenneth F. Buechler Ph.D., Chairman of the Board
- Douglas C. Bryant, President, Chief Executive Officer, Director
- Randall J. Steward, Chief Financial Officer
- Robert Joseph Bujarski J.D., Senior Vice President - Business Development, General Counsel and Corporate Secretary
- Michael D. Abney Jr., Senior Vice President - Distribution
- Werner Kroll Ph.D, Senior Vice President,R&D
- Edward Keith Russell, Senior Vice President - Global Commercial Operations
- Thomas D. Brown, Independent Director
- Mary Lake Polan M.D. Ph.D., Independent Director
- Jack W. Schuler, Independent Director
Who owns Quidel Corporation stock?
Quidel Corporation's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Trellus Management Company LLC (0.03%). Company insiders that own Quidel Corporation stock include Douglas C Bryant, John Tamerius, Michael Donald Jr Abney, Randall J Steward and Robert Joseph Bujarski. View Institutional Ownership Trends for Quidel Corporation.
Who sold Quidel Corporation stock? Who is selling Quidel Corporation stock?
Quidel Corporation's stock was sold by a variety of institutional investors in the last quarter, including Trellus Management Company LLC. Company insiders that have sold Quidel Corporation stock in the last year include Douglas C Bryant, John Tamerius, Michael Donald Jr Abney, Randall J Steward and Robert Joseph Bujarski. View Insider Buying and Selling for Quidel Corporation.
How do I buy Quidel Corporation stock?
Shares of Quidel Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Quidel Corporation's stock price today?
MarketBeat Community Rating for Quidel Corporation (NASDAQ QDEL)MarketBeat's community ratings are surveys of what our community members think about Quidel Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Quidel Corporation stock can currently be purchased for approximately $41.77.
Consensus Ratings for Quidel Corporation (NASDAQ:QDEL) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Hold Rating, 5 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.83)|
|Consensus Price Target: ||$47.50 (13.72% upside)|Consensus Price Target History for Quidel Corporation (NASDAQ:QDEL)
Analysts' Ratings History for Quidel Corporation (NASDAQ:QDEL)
(Data available from 10/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|9/19/2017||Canaccord Genuity||Reiterated Rating||Buy||$42.00 -> $48.00||High|
|9/19/2017||Barclays PLC||Reiterated Rating||Buy||$39.00 -> $45.00||High|
|9/19/2017||Raymond James Financial, Inc.||Reiterated Rating||Buy||$41.00 -> $47.00||High|
|9/19/2017||Piper Jaffray Companies||Upgrade||Neutral -> Overweight||$35.00 -> $50.00||High|
|7/18/2017||William Blair||Upgrade||Market Perform -> Outperform||High|
|2/17/2017||CL King||Initiated Coverage||Neutral||N/A|
|2/18/2016||Craig Hallum||Lower Price Target||Hold||$18.00 -> $16.00||N/A|
Earnings History for Quidel Corporation (NASDAQ:QDEL)Earnings History by Quarter for Quidel Corporation (NASDAQ QDEL)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|7/26/2017||Q2 2017||($0.17)||($0.35)||$41.91 million||$38.30 million||View||N/A|
|4/24/2017||Q1 2017||$0.15||$0.45||$61.85 million||$73.70 million||View||N/A|
|2/8/2017||Q416||$0.02||$0.17||$58.42 million||$52.80 million||View||Listen|
|10/26/2016||Q316||($0.02)||$0.10||$50.88 million||$49.30 million||View||Listen|
|7/27/2016||Q216||($0.25)||($0.11)||$37.98 million||$39.10 million||View||Listen|
|4/27/2016||Q116||($0.07)||$0.02||$49.21 million||$50.30 million||View||Listen|
|2/17/2016||Q415||$0.05||$0.10||$54.01 million||$52.40 million||View||Listen|
|10/28/2015||Q315||($0.14)||$0.05||$43.48 million||$46.80 million||View||Listen|
|7/22/2015||Q215||($0.25)||($0.14)||$34.17 million||$34.87 million||View||Listen|
|4/23/2015||Q115||$0.12||$0.30||$61.22 million||$61.30 million||View||Listen|
|2/11/2015||Q414||$0.10||$0.37||$60.61 million||$63.60 million||View||Listen|
|10/21/2014||Q314||($0.12)||($0.01)||$37.80 million||$40.90 million||View||Listen|
|7/22/2014||Q214||($0.16)||($0.10)||$31.90 million||$31.50 million||View||Listen|
|4/23/2014||Q114||$0.30||$0.08||$63.26 million||$46.70 million||View||Listen|
|2/11/2014||Q413||$0.09||$0.20||$48.67 million||$50.00 million||View||Listen|
|10/23/2013||Q313||($0.07)||($0.02)||$37.32 million||$33.50 million||View||Listen|
|7/30/2013||Q2 2013||($0.11)||($0.06)||$33.24 million||$29.71 million||View||Listen|
|4/23/2013||Q1 2013||$0.46||$0.49||$62.63 million||$61.99 million||View||N/A|
|2/12/2013||Q4 2012||$0.29||$0.26||$53.30 million||$53.93 million||View||Listen|
Earnings Estimates for Quidel Corporation (NASDAQ:QDEL)
2017 EPS Consensus Estimate: $0.26
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Quidel Corporation (NASDAQ:QDEL)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Quidel Corporation (NASDAQ:QDEL)
Insider Ownership Percentage: 22.00%Insider Trades by Quarter for Quidel Corporation (NASDAQ:QDEL)
Institutional Ownership Percentage: 87.17%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/29/2017||Douglas C Bryant||CEO||Sell||36,000||$42.91||$1,544,760.00|| |
|9/28/2017||Douglas C Bryant||CEO||Sell||12,000||$42.86||$514,320.00|| |
|9/27/2017||Douglas C Bryant||CEO||Sell||12,000||$42.17||$506,040.00|| |
|8/31/2017||Douglas C Bryant||CEO||Sell||36,000||$34.44||$1,239,840.00|| |
|7/31/2017||Douglas C Bryant||CEO||Sell||36,000||$33.83||$1,217,880.00|| |
|7/28/2017||Michael Donald Jr. Abney||SVP||Sell||1,173||$33.83||$39,682.59|| |
|7/28/2017||Randall J Steward||CFO||Sell||94,215||$34.09||$3,211,789.35|| |
|6/30/2017||Douglas C Bryant||CEO||Sell||36,000||$27.30||$982,800.00|| |
|5/31/2017||Douglas C Bryant||CEO||Sell||36,000||$24.98||$899,280.00|| |
|5/30/2017||Douglas C Bryant||CEO||Sell||12,000||$25.10||$301,200.00|| |
|5/26/2017||Douglas C Bryant||CEO||Sell||12,000||$24.90||$298,800.00|| |
|5/2/2017||Robert Joseph Bujarski||SVP||Sell||43,225||$24.27||$1,049,070.75|| |
|5/1/2017||Robert Joseph Bujarski||SVP||Sell||33,225||$24.20||$804,045.00|| |
|4/28/2017||Douglas C Bryant||CEO||Sell||36,000||$24.16||$869,760.00|| |
|3/31/2017||Douglas C Bryant||CEO||Sell||37,080||$22.50||$834,300.00|| |
|2/28/2017||Douglas C. Bryant||CEO||Sell||106,920||$21.39||$2,287,018.80|| |
|12/1/2016||Robert Joseph Bujarski||SVP||Sell||60,000||$22.84||$1,370,400.00|| |
|11/30/2016||Douglas C Bryant||CEO||Sell||72,000||$22.89||$1,648,080.00|| |
|11/29/2016||Douglas C Bryant||CEO||Sell||24,000||$22.84||$548,160.00|| |
|11/28/2016||Douglas C Bryant||CEO||Sell||24,000||$23.02||$552,480.00|| |
|11/25/2016||John Tamerius||SVP||Sell||8,878||$23.50||$208,633.00|| |
|9/30/2016||Douglas C Bryant||CEO||Sell||69,168||$21.76||$1,505,095.68|| |
|8/30/2016||Douglas C Bryant||CEO||Sell||2,832||$22.00||$62,304.00|| |
|8/9/2016||Robert Joseph Bujarski||SVP||Sell||22,057||$22.58||$498,047.06|| |
|8/1/2016||John Tamerius||SVP||Sell||7,000||$23.02||$161,140.00|| |
|2/19/2016||Douglas C. Bryant||CEO||Buy||3,700||$13.91||$51,467.00|| |
|12/2/2015||John Tamerius||SVP||Sell||21,109||$21.95||$463,342.55|| |
|10/30/2015||Douglas C Bryant||CEO||Buy||20,000||$19.76||$395,200.00|| |
|10/3/2014||John Tamerius||SVP||Sell||5,000||$28.00||$140,000.00|| |
|9/18/2014||John Tamerius||SVP||Sell||10,000||$26.50||$265,000.00|| |
|7/24/2014||Douglas C Bryant||CEO||Buy||20,000||$24.12||$482,400.00|| |
|7/23/2014||John Tamerius||SVP||Sell||15,000||$24.50||$367,500.00|| |
|6/24/2014||John Tamerius||SVP||Sell||5,000||$23.06||$115,300.00|| |
|2/26/2014||John Tamerius||SVP||Sell||47,246||$27.69||$1,308,241.74|| |
|2/13/2014||Rodney Dammeyer||Director||Sell||26,000||$27.70||$720,200.00|| |
|10/29/2013||Mark Pulido||Director||Sell||12,750||$25.31||$322,702.50|| |
|5/29/2013||Robert Joseph Bujarski||SVP||Sell||28,808||$23.16||$667,193.28|| |
|5/17/2013||Robert Joseph Bujarski||SVP||Sell||27,479||$23.12||$635,314.48|| |
Headline Trends for Quidel Corporation (NASDAQ:QDEL)
Latest Headlines for Quidel Corporation (NASDAQ:QDEL)
Loading headlines, please wait.
Quidel Corporation (QDEL) Chart for Saturday, October, 21, 2017